University of Oklahoma Confirms Cell Proliferation Inhibitory Effect of Novel Pancreatic Cancer Target Molecule Candidates Discovered by FRONTEO's AI Drug Discovery Support Service "Drug Discovery AI Factory"
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
FRONTEO and the University of Oklahoma have confirmed the cell proliferation inhibitory effect of novel pancreatic cancer target molecule candidates discovered by FRONTEO's AI drug discovery support service "Drug Discovery AI Factory." This collaborative research, which began in July 2025, will proceed to animal studies with the aim of creating new treatment options.